http://www.pdb.bnl.gov Griffith et al., Bone Morphogenetic-7, Dec. 14, 1995.* |
Hol (1986), “Protein Crystallography and Computer Graphics—Toward Rational Drug Design,” Angew. Chem. Int. Ed. Engagement. 25 No. 9:767-778. |
Martin (1991), “Computer-Assisted Rational Drug Design,” Meth. Enzymol. 203:587-613. |
Dixon (1992), “Computer-Aided Drug Design: Getting The Best Results,” TIBTECH 10:357-363. |
Bowen et al. (1993), “Computer-Assisted Molecular Modeling: Indispensible Tools For Molecular Pharmacology,” J. Clin. Pharmacol. 33:1149-1164. |
Tschinke et al. (1993), “The NEWLEAD Program: A New Method For The Design Of Candidate Structures From Pharmacophoric Hypotheses,” J. Med. Chem. 36, No. 24:3863-3870. |
Eisen et al. (1994), “HOOK: A Program For Finding Novel Molecular Architectures That Satisfy The Chemical And Steric Requirements Of A Macromolecule Binding Site,” Proteins: Structure, Function, and Genetics 19:199-221. |
Tomioka et al. (1994), “GREEN: A Program Package For Docking Studies In Rational Drug Design,” J. Computer-Aided Mol. Design 8:347-366. |
Waskowycz et al. (1994), “PRO LIGAND: An Approach To de Novo Molecular Design. 2. Design of Novel Molecules From Molecular Field Analysis (MFA) Models and Pharmacophores,” J. Med. Chem. 37, No. 23:3994-4002. |
Desjarlais et al. (1995), “De Novo Design Of The Hydrophobic Cores Of Proteins,” Protein Science 4:2006-2018. |
Struthers et al. (1996), “Design of a Monomeric 23-Residue Polypeptide With Defined Tertiary Structure,” Science 271:342-344. |
Bartlett et al. (1989) “CAVEAT: A Program To Facilitate The Structure-Derived Design of Biologically Active Molecules,” In Molecular Recognition: Chemical and Biological Problems (Roberts ed.) 182-196. |
Helder et al., “Expression Pattern of Osteogenic Protein-1 (Bone Morphogenetic Protein-7) in Human and Mouse Development,” J. Histochem. Cytochem., 43:1035-1044 (1995). |
Schlunegger et al., “An unusual feature revealed by the crystal structure at 2.2Å resolution of human tranforming growth factor-β2,” Nature, 358:430-434 (1992). |
Daopin et al., “Crystal Structure of Transforming Growth Factor-β2: An Unusual Fold for the Superfamily,” Science, 257:369-373 (1992). |
Griffith et al., “Three-dimensional structure of recombinant human osteogenic proteins 1; structural paradigm for the transforming growth factor beta superfamily,” Proceedings of the National Academy of Sciences of USA, 93(2); 878-883 (1996). |
Griffith et al., “Crystallization and Preliminary Crystallographic Data of Recominant Human Osteogenic Protein-1 (hOP-1),” J. Mol. Biol., 244:657-658 (1994). |
Griffith et al., “Crystal Structure of Recombinant Human Osteogenic Protein-1 (BMP-7),” J. of Bone and Mineral Research, vol. 10, Supplement 1, Abstract T 394, Seventeenth Annual Meeting of the American Society for Bone and Mineral Research, Sep. 9-13, 1995, 1st International Conference On Bone Morphogenetic Proteins, Jun. 8-11, 1994, Baltimore, Maryland. |